In this paper, we first carried out functional studies in melanoma cell lines to investigate the molecular role of miR-181a/b in melanoma, also raising evidence of their involvement in resistance to BRAF inhibitors-resistance in vitro and in clinical samples. This evidence concerns the gene BRAF and melanoma.